566944-05-6 Usage
Uses
Used in Pharmaceutical Research:
N-(6-isoquinolinyl)acetamide is used as a research compound for the development of new drugs and treatments, leveraging its unique chemical structure and potential biological activity.
Used in Organic Synthesis and Medicinal Chemistry:
N-(6-isoquinolinyl)acetamide is utilized as a building block in organic synthesis and medicinal chemistry, contributing to the creation of complex molecules and pharmaceutical agents.
Used in Toxicological Studies:
Due to its potential toxicity, N-(6-isoquinolinyl)acetamide is employed in toxicological studies to understand its effects on biological systems and to establish safe handling and usage protocols.
Used in Drug Development:
N-(6-isoquinolinyl)acetamide is used in the drug development process to explore its therapeutic potential and to identify possible applications in treating various diseases and conditions.
Note: The specific applications in different industries are not provided in the materials. The uses listed are inferred from the general potential of the compound in pharmaceutical and chemical research contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 566944-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,6,6,9,4 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 566944-05:
(8*5)+(7*6)+(6*6)+(5*9)+(4*4)+(3*4)+(2*0)+(1*5)=196
196 % 10 = 6
So 566944-05-6 is a valid CAS Registry Number.
566944-05-6Relevant academic research and scientific papers
Chen, Ping,Norris, Derek,Haslow, Kristin D.,Dhar, T. G. Murali,Pitts, William J.,Watterson, Scott H.,Cheney, Daniel L.,Bassolino, Donna A.,Fleener, Catherine A.,Rouleau, Katherine A.,Hollenbaugh, Diane L.,Townsend, Robert M.,Barrish, Joel C.,Iwanowicz, Edwin J.
, p. 1345 - 1348 (2003)
Screening of our in-house compound collection led to the discovery of 5-bromo-6-amino-2-isoquinoline 1 as a weak inhibitor of IMPDH. Subsequent optimization of 1 afforded a series of novel 2-isoquinolinoaminooxazole-based inhibitors, represented by 17, with single-digit nanomolar potency against the enzyme.
